Tuesday, December 08, 2020 12:59:48 PM
https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-receives-fda-rare-pediatric-disease-designation-for-acn00177-for-the-treatment-of-homocystinuria-301182095.html
Recent AGLE News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2024 08:36:43 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/01/2024 08:06:29 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/20/2024 11:14:05 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/18/2024 08:06:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2024 12:31:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/14/2024 08:12:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 09:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 12:33:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:36:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:33:03 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:32:12 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:27:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:25:02 PM
- Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treatment of IBD • PR Newswire (US) • 11/27/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/23/2023 01:45:06 AM
- Aeglea BioTherapeutics Announces Grants of Inducement Awards • PR Newswire (US) • 11/22/2023 10:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/15/2023 10:18:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 10:14:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 11/14/2023 08:13:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:10:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:06:30 PM
- Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update • PR Newswire (US) • 11/09/2023 09:05:00 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM